Abstract P6-10-02: Assessing biomarkers to inform treatment de-escalation: Mid-treatment biopsy cellularity predicts pCR in the I-SPY 2 Trial

Sara J. Venters, W. Fraser Symmans, Lamorna Brown Swigart et al.|Cancer Research|2020

Cited by 7